BioElectronics Corporation (BIEL)

BioElectronics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-0.29	-1.16	-2.33	-2.99	-2.12
Depreciation & Amortization	-	-	0	0	0
Stock-Based Compensation	0.01	0.16	-	0.2	0.07
Provision & Write-off of Bad Debts	0	0.02	0.06	0.07	0.03
Other Operating Activities	0.24	0.24	0.9	0.82	0.71
Change in Accounts Receivable	0.11	0.01	-0.18	-0.12	0.07
Change in Inventory	0.13	-0.05	0.2	0.15	0.14
Change in Accounts Payable	-0.07	0.01	0.86	0	0.25
Change in Unearned Revenue	-0.44	0.23	-0.23	0.51	0.02
Change in Other Net Operating Assets	-	0.01	0.01	-	-0.04
Operating Cash Flow	-0.32	-0.53	-0.72	-1.35	-0.87
Long-Term Debt Issued	0.56	0.89	1	1.69	0.93
Total Debt Issued	0.56	0.89	1	1.69	0.93
Long-Term Debt Repaid	-0.24	-0.16	-0.33	-0.21	-0.05
Total Debt Repaid	-0.24	-0.16	-0.33	-0.21	-0.05
Net Debt Issued (Repaid)	0.32	0.72	0.67	1.48	0.88
Other Financing Activities	-0.11	-0.13	-	-0.04	-0.01
Financing Cash Flow	0.21	0.59	0.67	1.44	0.87
Net Cash Flow	-0.11	0.06	-0.05	0.08	0
Free Cash Flow	-0.32	-0.53	-0.72	-1.35	-0.87
Free Cash Flow Margin	-19.90%	-63.65%	-75.99%	-129.31%	-49.26%
Cash Interest Paid	0.03	0.02	0.09	0.07	0.04
Levered Free Cash Flow	-0.55	-0.42	-0.73	-1.01	-0.73
Unlevered Free Cash Flow	-0.36	-0.25	-0.11	-0.42	-0.26
Change in Net Working Capital	0.28	-0.23	-0.71	-0.63	-0.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.